IPO - MANGOCEUTICALS, INC.

Form Type: S-1

Filing Date: 2025-05-30

Corporate Action: Ipo

Type: New

Accession Number: 000164117225013052

Filing Summary: Mangoceuticals, Inc., a Texas-based company, has filed a registration statement under the Securities Act of 1933 on May 30, 2025, for an initial public offering (IPO) of 4,461,718 shares of common stock. The offering includes shares to be sold by existing stockholders and those issuable upon the exercise of warrants and conversion of preferred stock. The company has not authorized any sales at this stage, and will not receive proceeds from these offerings. Their common stock is traded on the Nasdaq under the symbol 'MGRX'. As of May 27, 2025, the last reported share price was $1.89. The company provides telehealth services for men's wellness, offering products aimed at erectile dysfunction and other health concerns. The registration indicates a strategic move to gain capital and facilitate public trading of stock, targeting investors interested in the men’s wellness sector. The company has identified prospects for growth in telehealth, men's health products, and is also working on introducing a portfolio of compounded pharmaceuticals. This prospectus highlights the risks associated with investing in their common stock, which is subject to market and operational uncertainties.